Global Pulmonary Drug Delivery Devices & Systems Market Insights, Forecast to 2029

Publication ID:

PB504237717

Publication Date:

May 31, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
The global Pulmonary Drug Delivery Devices & Systems market is projected to grow from US$ 2923.3 million in 2023 to US$ 3741.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.
Report Includes:
This report presents an overview of global market for Pulmonary Drug Delivery Devices & Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pulmonary Drug Delivery Devices & Systems, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pulmonary Drug Delivery Devices & Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pulmonary Drug Delivery Devices & Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pulmonary Drug Delivery Devices & Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pulmonary Drug Delivery Devices & Systems sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics and SHL, etc.
By Company
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Segment by Type
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Segment by Application
Hospitals and Clinics
Homecare
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pulmonary Drug Delivery Devices & Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Drug Delivery Devices & Systems sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Pulmonary Drug Delivery Devices & Systems Product Introduction
1.2 Market by Type
1.2.1 Global Pulmonary Drug Delivery Devices & Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nebulizers
1.2.5 Accessories
1.3 Market by Application
1.3.1 Global Pulmonary Drug Delivery Devices & Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Homecare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pulmonary Drug Delivery Devices & Systems Sales Estimates and Forecasts 2018-2029
2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region
2.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region (2018-2023)
2.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue by Region (2024-2029)
2.2.4 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Region (2018-2029)
2.3 Global Pulmonary Drug Delivery Devices & Systems Sales Estimates and Forecasts 2018-2029
2.4 Global Pulmonary Drug Delivery Devices & Systems Sales by Region
2.4.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pulmonary Drug Delivery Devices & Systems Sales by Region (2018-2023)
2.4.3 Global Pulmonary Drug Delivery Devices & Systems Sales by Region (2024-2029)
2.4.4 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Manufacturers
3.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Manufacturers (2018-2023)
3.1.2 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Devices & Systems in 2022
3.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Manufacturers
3.2.1 Global Pulmonary Drug Delivery Devices & Systems Revenue by Manufacturers (2018-2023)
3.2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Devices & Systems Revenue in 2022
3.3 Global Key Players of Pulmonary Drug Delivery Devices & Systems, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pulmonary Drug Delivery Devices & Systems Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pulmonary Drug Delivery Devices & Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Product Offered and Application
3.8 Global Key Manufacturers of Pulmonary Drug Delivery Devices & Systems, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Type
4.1.1 Global Pulmonary Drug Delivery Devices & Systems Historical Sales by Type (2018-2023)
4.1.2 Global Pulmonary Drug Delivery Devices & Systems Forecasted Sales by Type (2024-2029)
4.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Type (2018-2029)
4.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Type
4.2.1 Global Pulmonary Drug Delivery Devices & Systems Historical Revenue by Type (2018-2023)
4.2.2 Global Pulmonary Drug Delivery Devices & Systems Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Type (2018-2029)
4.3 Global Pulmonary Drug Delivery Devices & Systems Price by Type
4.3.1 Global Pulmonary Drug Delivery Devices & Systems Price by Type (2018-2023)
4.3.2 Global Pulmonary Drug Delivery Devices & Systems Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pulmonary Drug Delivery Devices & Systems Sales by Application
5.1.1 Global Pulmonary Drug Delivery Devices & Systems Historical Sales by Application (2018-2023)
5.1.2 Global Pulmonary Drug Delivery Devices & Systems Forecasted Sales by Application (2024-2029)
5.1.3 Global Pulmonary Drug Delivery Devices & Systems Sales Market Share by Application (2018-2029)
5.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Application
5.2.1 Global Pulmonary Drug Delivery Devices & Systems Historical Revenue by Application (2018-2023)
5.2.2 Global Pulmonary Drug Delivery Devices & Systems Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share by Application (2018-2029)
5.3 Global Pulmonary Drug Delivery Devices & Systems Price by Application
5.3.1 Global Pulmonary Drug Delivery Devices & Systems Price by Application (2018-2023)
5.3.2 Global Pulmonary Drug Delivery Devices & Systems Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pulmonary Drug Delivery Devices & Systems Market Size by Type
6.1.1 US & Canada Pulmonary Drug Delivery Devices & Systems Sales by Type (2018-2029)
6.1.2 US & Canada Pulmonary Drug Delivery Devices & Systems Revenue by Type (2018-2029)
6.2 US & Canada Pulmonary Drug Delivery Devices & Systems Market Size by Application
6.2.1 US & Canada Pulmonary Drug Delivery Devices & Systems Sales by Application (2018-2029)
6.2.2 US & Canada Pulmonary Drug Delivery Devices & Systems Revenue by Application (2018-2029)
6.3 US & Canada Pulmonary Drug Delivery Devices & Systems Market Size by Country
6.3.1 US & Canada Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pulmonary Drug Delivery Devices & Systems Sales by Country (2018-2029)
6.3.3 US & Canada Pulmonary Drug Delivery Devices & Systems Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Type
7.1.1 Europe Pulmonary Drug Delivery Devices & Systems Sales by Type (2018-2029)
7.1.2 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Type (2018-2029)
7.2 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Application
7.2.1 Europe Pulmonary Drug Delivery Devices & Systems Sales by Application (2018-2029)
7.2.2 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Application (2018-2029)
7.3 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Country
7.3.1 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pulmonary Drug Delivery Devices & Systems Sales by Country (2018-2029)
7.3.3 Europe Pulmonary Drug Delivery Devices & Systems Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pulmonary Drug Delivery Devices & Systems Market Size
8.1.1 China Pulmonary Drug Delivery Devices & Systems Sales (2018-2029)
8.1.2 China Pulmonary Drug Delivery Devices & Systems Revenue (2018-2029)
8.2 China Pulmonary Drug Delivery Devices & Systems Market Size by Application
8.2.1 China Pulmonary Drug Delivery Devices & Systems Sales by Application (2018-2029)
8.2.2 China Pulmonary Drug Delivery Devices & Systems Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pulmonary Drug Delivery Devices & Systems Market Size by Type
9.1.1 Asia Pulmonary Drug Delivery Devices & Systems Sales by Type (2018-2029)
9.1.2 Asia Pulmonary Drug Delivery Devices & Systems Revenue by Type (2018-2029)
9.2 Asia Pulmonary Drug Delivery Devices & Systems Market Size by Application
9.2.1 Asia Pulmonary Drug Delivery Devices & Systems Sales by Application (2018-2029)
9.2.2 Asia Pulmonary Drug Delivery Devices & Systems Revenue by Application (2018-2029)
9.3 Asia Pulmonary Drug Delivery Devices & Systems Sales by Region
9.3.1 Asia Pulmonary Drug Delivery Devices & Systems Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pulmonary Drug Delivery Devices & Systems Revenue by Region (2018-2029)
9.3.3 Asia Pulmonary Drug Delivery Devices & Systems Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Market Size by Type
10.1.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Market Size by Application
10.2.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country
10.3.1 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pulmonary Drug Delivery Devices & Systems Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hovione
11.1.1 Hovione Company Information
11.1.2 Hovione Overview
11.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hovione Recent Developments
11.2 3M Health Care
11.2.1 3M Health Care Company Information
11.2.2 3M Health Care Overview
11.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 3M Health Care Recent Developments
11.3 Bespak
11.3.1 Bespak Company Information
11.3.2 Bespak Overview
11.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bespak Recent Developments
11.4 BeyonDevices
11.4.1 BeyonDevices Company Information
11.4.2 BeyonDevices Overview
11.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BeyonDevices Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 H&T Presspart
11.6.1 H&T Presspart Company Information
11.6.2 H&T Presspart Overview
11.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 H&T Presspart Recent Developments
11.7 PARI Respiratory Equipment
11.7.1 PARI Respiratory Equipment Company Information
11.7.2 PARI Respiratory Equipment Overview
11.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PARI Respiratory Equipment Recent Developments
11.8 Philips Respironics
11.8.1 Philips Respironics Company Information
11.8.2 Philips Respironics Overview
11.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Philips Respironics Recent Developments
11.9 SHL
11.9.1 SHL Company Information
11.9.2 SHL Overview
11.9.3 SHL Pulmonary Drug Delivery Devices & Systems Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 SHL Pulmonary Drug Delivery Devices & Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SHL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pulmonary Drug Delivery Devices & Systems Industry Chain Analysis
12.2 Pulmonary Drug Delivery Devices & Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pulmonary Drug Delivery Devices & Systems Production Mode & Process
12.4 Pulmonary Drug Delivery Devices & Systems Sales and Marketing
12.4.1 Pulmonary Drug Delivery Devices & Systems Sales Channels
12.4.2 Pulmonary Drug Delivery Devices & Systems Distributors
12.5 Pulmonary Drug Delivery Devices & Systems Customers
13 Market Dynamics
13.1 Pulmonary Drug Delivery Devices & Systems Industry Trends
13.2 Pulmonary Drug Delivery Devices & Systems Market Drivers
13.3 Pulmonary Drug Delivery Devices & Systems Market Challenges
13.4 Pulmonary Drug Delivery Devices & Systems Market Restraints
14 Key Findings in The Global Pulmonary Drug Delivery Devices & Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂